Transcript
Page 1: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 33

CLINICAL REVIEW

BY DEREK MACDONALD, OD, FAAO

Introduction

For a disease recognized as a common cause of irreversible

vision loss, a universally agreed--

-1 Primary open-angle glaucoma

--

3

--

4

only pressure-dependent optic neuropathy.5

be abandoned in favour of viewing -

-

Epidemiology and Risk Factors

8

common, more severe, and more

serious disease.11-13 -

Under pressure: a review of normal-tension glaucoma

En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse aura une pression intraoculaire se situant à l’intérieur des limites de la normale et recevra le diagnostic de glaucome à tension normale. Les professionnels des soins oculovisuels (et leurs patients) auront intérêt à bien connaître le diagnostic, le traitement et le pronostic de cette condition et à bien comprendre non seulement les similitudes et les di!érences avec le glaucome primaire à angle ouvert mais les rôles importants joués par le système nerveux central et l’état vasculaire systémique.

Mots clés : Glaucome à tension normale (GTN), glaucome primaire à angle ouvert (GPAO), hystérèse cornéenne (HC), hémorragie discale (HD), atrophie péripapillaire de la zone bêta (APP!), pression de perfusion oculaire (PPO), dysrégulation vasculaire, pression du liquide céphalorachidien (PLCR), di"érence de pression à travers la lame criblée, neuroprotection

RÉSUMÉ

Page 2: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201234

14 -

-

-

Pathophysiology – Under Pressure

-

-versally.19

-

-

-

-

-

-

31

cc

encompassing a more global corneal

cc

33

-34

35

On average, every third patient with glaucomatous optic neuropathy will present with intraocular pressure within the statistically normal range, manifesting normal-tension glaucoma. Eye care practitioners (and their patients) will bene"t from a familiarity with the diagnosis, treatment, and prognosis of this condition, including similarities to, and di!erences from, primary open-angle glaucoma, and the important roles played by the central nervous system and systemic vascular status.

Key words: normal-tension glaucoma (NTG), primary open-angle glaucoma (POAG), corneal hysteresis (CH), disc hemorrhage (DH), beta-zone peripapillary atrophy (!PPA), ocular perfusion pressure (OPP), vascular dysregulation, cerebrospinal #uid pressure (CSFP), trans-lamina cribrosa pressure di"erential, neuroprotection

ABSTRACT

Page 3: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 35

in generalized poor perfusion. -

decreased vascular perfusion,

demands.38

without cardio-

-

-

8,38

-sion causing low ocular perfusion

39-41

44,45

48,49

without -

-

53

-

-

4,14

-

-

-55

Episodic vaso-

35

-

39

-

58,59

-

Page 4: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201236

-

-

-

Structural Change

-

migraine.

-

83-88

of migraine.

diagnosis.91

-83

overlooked during clinical exam as -

diagnosis.

Page 5: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 37

loss.

-ing conversion.94

99

Eyes

-

progression.

-

-

-

requiring more aggressive pressure

-

parapapillaryperipapillary

-mal eyes,

Many believe

severe disease. -

-

diagnosis.113-115

large areas of

115

secondary

Page 6: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201238

114

of

-

Functional Change

118

-

93

year.99

-

119

-

-

measures.

-

Management

-

19

8

low pressures.

-ered.131-134

-135

-

Page 7: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 39

135

-

-

-

-

-19

-

138

139

-

141

-

-

-

Page 8: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201240

Conclusion

-

--

References

Arch Ophthalmol

Can J Ophthalmol

Arch Ophthalmol

Can J Ophthalmol

Arch Ophthalmol

glaucoma. Arch Ophthalmol

Br J Ophthalmol

glaucoma. Am J Ophthalmol

Ophthalmol

Br J Ophthalmol

angle glaucoma? Curr Opin Ophthalmol

Am J Ophthalmol

glaucoma under ß-blocker Acta Ophthalmol

primary open angle glaucoma versus

Curr Eye Research

glaucoma. J Glaucoma

Open Ophthalmol J

Mol Vis

PLoS Genetics

progression. Arch Ophthalmol

Curr Opin Ophthalmol

Invest Ophthalmol Vis Sci

lens sensor. Arch Ophthalmol

Acta Ophthalmol Scand

Arch Ophthalmol

differences in glaucoma: prevalence, Curr Opin

Ophthalmol

and prevalence of primary open-angle glaucoma. J Nat Med Assoc

Arch Ophthalmol

Arch Ophthalmol

Eye

of glaucoma. Curr Opin Ophthalmol

Page 9: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 41

This case encapsulates the diagnostic dilemma of NTG.The patient in question is a 51-year old myopic (-7.00D) Asian female who discontinued treatment with prostaglandin analog two years ago. She takes no systemic medications, and denies any symptoms of sys-temic vascular dysregulation. Her IOPs are 14 and 15mmHg; her CCTs are 494 and 493 microns.The right ONH (top photo) is obliquely inserted, with superior temporal DH, inferior temporal #PPA, and adjacent RNFL defect. The left ONH shows inferior temporal NRR thinning with adjacent RNFL defect. Initial VF analysis (albeit with questionable reliability; con"rma-tion pending) shows an early supe-rior nasal step in both right and left. Her GP is being consulted to ensure that her systemic vascular status is satisfactory. Pending con"rmatory VF analyses, topical treatment with prostaglandin analog (with a target pressure approaching the episcleral venous pressure of ~10mmHg) is likely to be initiated.

RIGHT EYEFIXATION LOSSES: 0/13FALSE POS ERRORS: 9%FALSE NEG ERRORS: 4%TEST DURATION: 03:28

Appendix – Illustrative Case Presentation

LEFT EYEFIXATION LOSSES: 5/12 xxFALSE POS ERRORS: 18% xxFALSE NEG ERRORS: 11%TEST DURATION: 03:45

EXCESSIVE HIGH FALSE POSITIVES***

GHTOUTSIDE NORMAL LIMITSVFI 97%MD –0.03 dBPSD 2.30 dB P<5%

GHTOUTSIDE NORMAL LIMITSVFI 97%MD –0.98 dBPSD 2.67 dB P<2%

Page 10: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201242

J Glaucoma

Am J Ophthalmol

open-angle glaucoma. BMC Ophthalmol

glaucoma. J Glaucoma

Prog Ret Eye Research

glaucoma. Ophthalmol

pressure in glaucoma. Clin Exp Optom

Clin Ophthalmol

Arch Ophthalmol

Ophthalmologica

in glaucoma: a review. Clin Experiment Ophthalmol

angle glaucoma. Can J Ophthalmol

Ophthalmol

pressure, perfusion pressure, and glaucoma. Am J Ophthalmol

Invest Ophthalmol Vis Sci

Blood Pressure

Jpn J Ophthalmol

glaucoma. Arch Ophthalmol

Am J Ophthalmol

progression. Invest Ophthalmol Vis Sci

Invest Ophthalmol Vis Sci

in glaucoma. Expert Rev Ophthalmol

J Human Hypertension

Can J Ophthalmol

Arch Ophthalmol

glaucoma. Br J Ophthalmol

Br J Ophthalmol

glaucoma. Acta Ophthalmol

of primary open-angle glaucoma? Ophthalmol

Medical Hypotheses

pressure in glaucoma. Ophthalmol

Acta Ophthalmol

in primary open angle glaucoma,

Invest Ophthalmol Vis Sci

pressure is decreased in primary open-angle glaucoma. Ophthalmol

in glaucoma? Medical Hypotheses

Br J Ophthalmol

BMC Neurology

Ophthalmol

Page 11: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

VOL 74 | NO 4 2012C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I E 43

Arch Ophthalmol

Asian J Ophthalmol

Optom Vis Sci

Arch Ophthalmol

Arch Ophthalmol

Invest Ophthalmol Vis Sci

Ophthalmol

glaucomas. Surv Ophthalmol

glaucoma. Ophthalmol

Graefes Arch Clin Exp Ophthalmol

pressure. Arch Ophthalmol5.

Invest Ophthalmol Vis Sci

J Glaucoma

Am J Ophthalmol

Ophthalmol

Ophthalmol

Arch Ophthalmol

Br J Ophthalmol

HKI Ophthalmol

glaucoma and primary open-angle glaucoma. Clin Experiment Ophthalmol

Eye

Arch Ophthalmol

Clin Experiment Ophthalmol

Am J Ophthalmol

loss in progressive glaucoma. Arch Ophthalmol

Arch Ophthalmol

Am J Ophthalmol

glaucoma. Arch Ophthalmol

Arch Ophthalmol

Am J Ophthalmol

Ophthalmol

PLoS ONE

J Glaucoma

Ophthalmol

Arch Ophthalmol

Am J Ophthalmol

glaucoma eyes. Invest Ophthalmol Vis Sci

Ophthalmol

progression. Ophthalmol

Page 12: Under pressure: a review of normal-tension glaucomaUnder pressure: a review of normal-tension glaucoma En moyenne, un patient sur trois atteint de neuropathie optique glaucomateuse

C A N A D I A N J O U R N A L O F O P T O M E T R Y | R E V U E C A N A D I E N N E D ’ O P T O M É T R I EVOL 74 | NO 4 201244

myopia. Ophthalmol

Graefes Arch Clin Exp Ophthalmol

glaucoma. Ophthalmol

for glaucoma progression: disc

Asia-Pac J Ophthalmol

pressure glaucoma. Am J Ophthalmol

Ophthalmol

glaucoma. Clin Ophthalmol

Ophthalmol Vis Sci

glaucoma eyes. Invest Ophthalmol Vis Sci

angle glaucoma. Asian J Ophthalmol

Am J Ophthalmol

Ophthalmol

Arch Ophthalmol

Invest Ophthalmol Vis Sci

Graefes Arch Clin Exp Ophthalmo81.

J Glaucoma

Br J Ophthalmol

Invest Ophthalmol Vis Sci

J Glaucoma

Ophthalmol

Ophthalmol

pressure and glaucoma progression. Arch Ophthalmol

Ophthalmol

Ophthalmol

newly diagnosed open-angle glaucoma. Arch Ophthalmol

Arch Ophthalmol

Am J Ophthalmol

Surv Ophthalmol

Ophthalmol

dorzolamide. BMC Ophthalmol

BMC Ophthalmol

for glaucoma? Arch Ophthalmol

Ophthalmol

Can J Ophthalmol

in glaucoma. Am J Ophthalmol

Clin Ophthalmol


Recommended